Form 4: CONMED CFO Exercises RSUs, Covers Taxes

CONMED's Executive Vice President and CFO, Todd W. Garner, exercised restricted stock units and subsequently sold a portion of the resulting common stock to cover tax obligations.

Summary

• Todd W. Garner, Executive Vice President & CFO of CONMED Corp, reported transactions on October 31, 2025.
• Mr. Garner exercised 7,500 Restricted Stock Units (RSUs), converting them into 7,500 shares of common stock at an exercise price of $0.
• He disposed of 2,164 shares of common stock at a price of $44 per share to satisfy tax withholding obligations related to the RSU vesting.
• Following these transactions, Mr. Garner directly beneficially owns 5,336 shares of common stock and 15,227 Restricted Stock Units.
• The RSUs are subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, vesting over two years with 33% after year 1 and 67% after year 2.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction involving the exercise of restricted stock units and a subsequent sale of shares to cover tax obligations. This is a standard event in executive compensation and does not inherently indicate positive or negative sentiment regarding the company's performance or outlook.

Positives

• Vesting of 7,500 Restricted Stock Units (RSUs) indicates the achievement of performance or tenure conditions for executive compensation.
• The exercise price of $0 for the RSUs represents a direct gain for the executive upon vesting.

Negatives

• Disposition of 2,164 shares of common stock, even for tax purposes, reduces the executive's direct equity holding in the company.

Future Outlook

NA

Industry Context

This is a routine executive compensation event, common across publicly traded companies where executives receive equity-based awards like RSUs as part of their incentive plans. The subsequent sale of shares to cover tax obligations upon vesting is also a standard practice.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a component of executive compensation is a widely adopted practice in the medical technology and broader corporate sectors, aligning executive incentives with shareholder value creation over time.
• The practice of selling a portion of vested shares to cover tax liabilities (known as "sell-to-cover") is a standard and common method for executives to manage the tax implications of equity awards, observed across companies like Medtronic, Stryker, and Zimmer Biomet.
• The vesting schedule of RSUs over two years (33% after year 1, 67% after year 2) is within typical industry ranges for long-term incentive plans, which often span 2-4 years to promote retention and long-term performance.

Stakeholder Impact

• Shareholders: Minimal direct impact. This is a routine compensation event and a small, tax-related disposition of shares by an executive. It does not signal a change in company fundamentals or strategy.
• Employees: No direct impact.
• Management: The vesting and exercise of RSUs are part of the executive's compensation package, aligning their interests with long-term company performance.

Key Dates

Keywords

CONMED, CNMD, Form 4, insider transaction, RSU, restricted stock units, executive compensation, stock vesting, tax withholding, Todd W. Garner